Results 221 to 230 of about 103,945 (310)
Invasion prediction with artificial intelligence in ductal carcinoma in situ (DCIS) patients: a proof-of-concept study. [PDF]
Gundogdu A +5 more
europepmc +1 more source
Progress in RNA‐Targeted Therapeutics for Human Diseases
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang +10 more
wiley +1 more source
Integrating Multiple Methods to Validate Key Genes Driving the Progression of Breast Ductal Carcinoma In Situ. [PDF]
Zhong M +8 more
europepmc +1 more source
H. pylori infection is a major cause of stomach cancer, but its effect on immune cells in tumors is unclear. Using single‐cell sequencing, we mapped the stomach tumor environment and discovered a specific exhausted T‐cell subtype, marked by the FYB1 gene, that is abundant in H. pylori‐positive tumors and linked to patient prognosis. Our findings reveal
Yanhui Yang +22 more
wiley +1 more source
Mitigating overtreatment of ductal carcinoma in situ. [PDF]
Chung HL +3 more
europepmc +1 more source
Genome evolution in ductal carcinoma in situ: invasion of the clones
Anna K. Casasent, M. Edgerton, N. Navin
semanticscholar +1 more source
Contesting the C Word: The Diagnosis of DCIS and Women's Resistance Against Overtreatment
ABSTRACT DCIS, or ductal carcinoma in situ—also known as Stage 0 breast cancer—accounts for approximately 20 per cent of new breast cancer cases. Although it is noninvasive, treatment typically mirrors that of invasive cancer. Whether DCIS is overtreated remains controversial, even among medical professionals.
Chien‐Juh Gu
wiley +1 more source
Race-related subsequent breast events after ductal carcinoma in situ: A Surveillance, Epidemiology, and End Results-based analysis. [PDF]
Koric A, Jiang S, Liu Y, Colditz GA.
europepmc +1 more source
This study indicates that SPP1, as an important regulator of tumor progression, is upregulated in various tumors and has been associated with a poor prognosis. SPP1+M2 has a unique spatial location at the forefront of tumor invasion and metastasis, thereby promoting tumor progression. MARCO+M2, which forms a mutually exclusive relationship with SPP1+M2,
Xuan Luo +15 more
wiley +1 more source

